What is the global market size of Wearable Injectors Market?

Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030).

Who are the key vendors in the Global Wearable Injectors Market?

Many businesses in the market for producing wearable injectors are now concentrating on expanding their production capacities through mergers and acquisitions. For the purpose of acquiring new features or gaining entry into new markets, large primary manufacturers are creating joint ventures or purchasing small or midsized businesses. Additionally, businesses are investing in the creation of enhanced products. They are also concentrating on keeping their prices competitive. For instance, in April 2021, the Medtronic Extended infusion set is the first and only infusion set that may be worn for up to 7 days, according to an announcement made by Medtronic plc. 'Ypsomed', 'Amgen', 'Subcuject (Denmark)', 'Becton, Dickinson and Company (BD)', 'Bespak Europe Ltd.', 'CeQur SA', 'Debiotech SA', 'Enable Injections', 'Insulet Corporation', 'Medtronic plc', 'Mylan N.V.', 'Nemera Development S.A.', 'Omron Corporation', 'Pfizer Inc.', 'Roche Holding AG', 'Sensile Medical AG', 'SteadyMed Therapeutics, Inc.', 'Tandem Diabetes Care, Inc.', 'United Therapeutics Corporation', 'West Pharmaceutical Services, Inc.', 'Zosano Pharma Corporation'

What is the key driver of Global Wearable Injectors Market?

The choice of different medicines and wearable drug delivery systems has increased as a result of the uncertainty surrounding the COVID-19 pandemic. To stop the illness from spreading and protect high-risk individuals from illness, medical systems on the planet have taken action to delay the onset of cancer therapies. As the pandemic spread, the risks for those obtaining medical attention increased. The majority of patients are treated in hospitals, which increased their danger during the outbreak. A shift from hospital-based therapy to home-based care has taken place in order to solve these challenges and give adequate care to individuals suffering from various illnesses.

What is the key market trend for Global Wearable Injectors Market?

The rising popularity of at-home, self-administered injectors for treating illnesses with little chance of dosage error and needle stick injuries. Other growth-promoting aspects include a number of product developments, such as the incorporation of Bluetooth, wireless communication, and passive warning systems with injectors. These innovations allow for comfortable patient monitoring via a mobile application and offer prompt medication reminders.

Which region accounted for the largest share in Global Wearable Injectors Market?

In terms of revenue, North America held the largest wearable injector market globally in 2021, and it is expected that it will continue to do so during the projection timeframe. This is explained by the spike in the number of people with various medical conditions. Furthermore, the requirement for the wearable injector market is being fueled by the introduction of numerous novel medications that may successfully cure chronic diseases. Additionally, the growing acceptance of tailored pharmaceuticals may have a favorable effect on the market in the years to come.

Wearable Injectors Market Size, Share, Growth Analysis, By Type(On-Body, Off-Body), By Therapy(Diabetes, Cardiovascular Disease, Oncology, Infectious Disease), By End Use(Home care and Hospital), By Region - Industry Forecast 2024-2031

Report ID: SQSG35B2020 | Region: Global | Published Date: February, 2024
Pages: 263 | Tables: 63 | Figures: 76

Wearable Injectors Market Competitive Landscape

Top Players in the Global Wearable Injector Market

Ypsomed
Amgen
Subcuject (Denmark)
Becton, Dickinson and Company (BD)
Bespak Europe Ltd.
CeQur SA
Debiotech SA
Enable Injections
Insulet Corporation
Medtronic plc
Mylan N.V.
Nemera Development S.A.
Omron Corporation
Pfizer Inc.
Roche Holding AG
Sensile Medical AG
SteadyMed Therapeutics, Inc.
Tandem Diabetes Care, Inc.
United Therapeutics Corporation
West Pharmaceutical Services, Inc.
Zosano Pharma Corporation

Wearable Injectors Market Recent Development

In 2023, Enable Injections, Inc. expects 2023.2. and a U.S.-based biotechnology company of Viridian Therapeutics, Inc.; united, and extended the joint effort.
In 2023, Tandem Diabetes Care, Inc. is expected to have 1.5% of its revenue. increased by 0.08%. has completed the acquisition of AMF Medical SA, known for its Sigi Patch Pump, strengthening its portfolio.
In 2022, AbbVie acquired U.S. the FDA approved SKYRIZI, an interleukin-23 inhibitor, for the treatment of moderate-to-severe active Crohn’s disease. It is administered by subcutaneous injection, allowing patients to opt for self-administration with an On-Body Injector.

Wearable Injectors Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Wearable Injectors Market size was valued at USD 6.66 billion in 2019 and is poised to grow from USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031).

The market is fragmented with high competition worldwide due to the presence of major key players. These players focus on growth strategies, such as new product launches, collaborations, partnerships, business expansions, mergers & acquisitions, and patient campaigns in March 2021. Aptar and Noble International dne pharma, North European addiction treatment the first to announce a collaborative implementation the innovative Unidos Liquid system by Ventizolv, Aptar and Noble. The partnership aims to prevent the potentially deadly effects of opioid overdoses in Europe as soon as possible. 'Ypsomed', 'Amgen', 'Subcuject (Denmark)', 'Becton, Dickinson and Company (BD)', 'Bespak Europe Ltd.', 'CeQur SA', 'Debiotech SA', 'Enable Injections', 'Insulet Corporation', 'Medtronic plc', 'Mylan N.V.', 'Nemera Development S.A.', 'Omron Corporation', 'Pfizer Inc.', 'Roche Holding AG', 'Sensile Medical AG', 'SteadyMed Therapeutics, Inc.', 'Tandem Diabetes Care, Inc.', 'United Therapeutics Corporation', 'West Pharmaceutical Services, Inc.', 'Zosano Pharma Corporation'

Increasing incidence of chronic conditions such as diabetes, cardiovascular diseases and cancer is a major driver for the wearable injectors market. These devices provide a convenient and it is less painful to administer medications to patients, resulting in better patient compliance. As the global burden of chronic diseases increases, especially in the elderly population, injectable wear is expected to continue to increase.

Shift towards Personalized Medicine: A growing trend in the wearable injector market is the shift towards personalized medication delivery. With more and more biopharmaceutical companies developing products tailored to individual patients, wearable injectables are increasingly being developed to meet personalized treatment regimens. This trend improves not only patient outcomes but also does accuracy, reviving the demand for wearable injectables.

North America play a dominant role in the growth of the wearable injectors market, each with distinctive factors driving their growth. North America especially the US. leading to improved healthcare, increasing acceptance of new technologies. In addition to the strong emphasis on home health through the presence of pharmaceutical and medtech companies, chronic diseases such as diabetes and cancer are on the way higher increases the demand for wearable injectables in this region. North America’s favourable reimbursement and regulatory policies and support the region. The region is also an R&D hub, which provides technologies internal growth occurs in drug delivery systems, making it a key player in market growth.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Wearable Injectors Market Size, Share, Growth Analysis, By Type(On-Body, Off-Body), By Therapy(Diabetes, Cardiovascular Disease, Oncology, Infectious Disease), By End Use(Home care and Hospital), By Region - Industry Forecast 2024-2031

Wearable Injectors Market Competitive Landscape

Wearable Injectors Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Wearable Injectors Market?

Who are the key vendors in the Wearable Injectors Market?

What is the key driver of Wearable Injectors Market?

What is the key market trend for Wearable Injectors Market?

Which region accounted for the largest share in Wearable Injectors Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300